SILEXION THERAPEUTICS CORP Operating Lease Liability
SILEXION THERAPEUTICS CORP (SLXN) had Operating Lease Liability of $468.00 thousand as of 2025-12-31, per its S-1/A filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-10
- 2025-12-31: Operating Lease, Liability $468.00K.
- 2024-12-31: Operating Lease, Liability $526.00K.
- 2023-12-31: Operating Lease, Liability $171.00K.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $468.00K S-1/A · filed 2026-08-10 |
| 2024-12-31 | $526.00K 8-K · filed 2025-08-20 |
| 2023-12-31 | $171.00K 8-K · filed 2025-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |